Find Academic Supervisors

Dr. Lucian Sulica is the Sean Parker Professor of Laryngology and Director of the Sean Parker Institute for the Voice at Weill Cornell Medical College. He is an attending Otolaryngologist at NewYork-Presbyterian Hospital with a clinical practice exclusively focused on voice disorders. Dr. Sulica served as the 2023 President of the American Laryngological Association and is a Fellow of the American Laryngologic, Rhinologic and Otologic Society (the Triologic Society). His educational background includes: A.B. from Dartmouth College (1989) M.D. from Georgetown University School of Medicine (1993) Residency at Georgetown University Medical Center Fellowship at New York Center for Voice & Swallowing Disorders, St. Luke's-Roosevelt Hospital Center Dr. Sulica's research focuses on evidence-driven principles for treating voice conditions, with particular emphasis on vocal fold injuries from voice use (especially in performers), neurologic voice disorders (including vocal fold paralysis, spasmodic dysphonia, and tremor), and in-office procedures for voice disorders that don't require general anesthesia. His work has addressed critical aspects such as gender differences in vocal fold injury, pathophysiology of laryngeal nerve injury, and diagnostic accuracy in voice disorders. Analysis of Dr. Sulica's recent publications reveals a strong focus on advancing diagnostic techniques through artificial intelligence, improving surgical outcomes for vocal fold lesions, understanding performers' unique voice care needs, and developing evidence-based protocols for vocal fold hemorrhage and other voice disorders. His research increasingly incorporates technology-driven approaches while maintaining a strong clinical focus on patient-centered outcomes. Dr. Sulica has received numerous prestigious awards including: Casselberry Award of the American Laryngological Association (2021) Felix Semon Lectureship in Laryngology, Royal Society of Medicine (2022) American Academy of Otolaryngology – Head & Neck Surgery Honor Award (2008) Consistent recognition as one of "Best Doctors in America" (2005-2024) Designation as one of "America's Top Physicians in Voice Disorders/Laryngology" (since 2006) Inclusion in "New York Magazine Best Doctors" list annually since 2013 As an educator, Dr. Sulica has authored more than 110 journal articles and 40 book chapters, and has edited three books including "Vocal Fold Paralysis," "Classics in Voice and Laryngology," and "Patologia Laringea y Fonocirugia" (in Spanish). He is passionate about teaching and has lectured extensively across the United States, Europe, Latin America, and Australia. His clinical work at the Sean Parker Institute for the Voice represents a comprehensive approach to voice care, incorporating innovative in-office procedures that have helped establish new standards in laryngology.

• Voice Disorders
• Laryngology
• Vocal Fold Injuries
• +7 more

Christine Clark, MD, MSc is an attending laryngologist at Weill Cornell Medicine’s Sean Parker Institute for the Voice and Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Weill Cornell Medical College. She earned her B.A. from the University of Pittsburgh (2011) and her M.D. from Pennsylvania State University College of Medicine (2017), followed by residency at Georgetown University Medical Center and a fellowship in Laryngology at Weill Cornell, where she also obtained a master’s degree in Clinical and Translational Science. B.A. - University of Pittsburgh (2011) M.D. - Pennsylvania State University College of Medicine (2017) Residency - Georgetown University Medical Center Fellowship - Sean Parker Institute for the Voice (Laryngology) Master’s - Clinical and Translational Science at Weill Cornell Dr. Clark specializes in evaluating and treating swallowing, voice, and airway disorders. Her research focuses on chronic cough, laryngeal hypersensitivity, and benign phonotraumatic vocal fold lesions. She has developed clinical tools like the 3D-printed injection laryngoplasty simulator and quality improvement initiatives for surgical airway management. Her clinical work and research span topics such as vocal fold hemorrhage management, pharyngeal residue quantification in dysphagia, and granuloma as markers of malignancy. Recent publications emphasize global otolaryngology capacity building and performer-specific voice injury care. Scientific awards include: Teaching awards for excellence in medical student education during residency Dr. Clark is affiliated with the Sean Parker Institute for the Voice at Weill Cornell Medicine and serves as an Assistant Professor of Otolaryngology.

• Otolaryngology
• Laryngology
• Voice Disorders
• +5 more

Jeff Searl is a Professor in the Department of Communicative Sciences and Disorders at Michigan State University (MSU), within the College of Communication Arts and Sciences. Previously, he held faculty roles at the University of Kansas Medical Center’s Hearing and Speech Department and the Otolaryngology – Head & Neck Surgery Department. He earned his Ph.D. from the University of Kansas. His research focuses on understanding how chemoradiation and surgery for head and neck cancers affect speech and voice production. The goal is to develop clinical practices that preserve or rehabilitate communication for patients post-treatment. His methods include physiological, acoustic, and auditory-perceptual measurements. Key emphases include optimizing communication while balancing speech intelligibility, physical/cognitive effort, and associated fatigue. Recent work addresses pandemic impacts on laryngectomy patients, clinician practices during crises, and vocal effort measurement across cultures. His lab investigates articulatory pressures, tracheoesophageal speech dynamics, and dysphagia treatment innovations. Though no specific awards are listed, his contributions to voice rehabilitation and clinical methodologies are significant. Dr. Searl advises on telemedicine applications for Parkinson’s voice therapy, group therapy feasibility, and alaryngeal communication modalities. His lab at MSU collaborates on interdisciplinary projects involving speech-language pathologists, engineers, and oncologists to advance communication restoration technologies.

• Speech Production
• Head and Neck Cancer Rehabilitation
• Voice Assessment
• +3 more

Dr. Weitao Wang serves as an Assistant Professor in the Department of Otolaryngology at the University of Rochester School of Medicine and Dentistry. Board-certified in both Otolaryngology-Head and Neck Surgery and Facial Plastic and Reconstructive Surgery, he practices clinically at UR Medicine and the Wilmot Cancer Institute in Rochester, NY, specializing in complex head and neck reconstruction and facial plastic procedures. Medical Degree: University of Virginia School of Medicine Residency: Otolaryngology-Head and Neck Surgery, University of Rochester Medical Center (2015-2019) Fellowship: Facial Plastic and Reconstructive Surgery, The Institute for Rehabilitation and Research (2019-2020) His research focuses on advancing head and neck reconstruction through tissue engineering (particularly bone/cartilage grafting) and optimizing surgical education via point-of-view video technology. Clinical investigations prioritize patient-reported outcomes in facial plastic surgery to enhance functional recovery and satisfaction metrics. Current work bridges engineering solutions with complex defect reconstruction. Recent publications (2020-2025) demonstrate concentrated expertise in microvascular free tissue transfer, virtual surgical planning for craniofacial defects, and innovative skull base/orbital reconstruction techniques. His work consistently addresses oncologic safety while improving functional outcomes in head and neck cancer patients, with increasing emphasis on cost-effective surgical training methodologies. Robert Joynt Kindness Award 2021 Leslie Bernstein Resident Research Grant: Optimizing bone allograft in craniofacial defect reconstruction Wallace K. Dyer Clinical Investigation Grant: Cost-effective surgeon POV video in otolaryngology training Dr. Wang secures competitive funding from the American Academy of Facial Plastic and Reconstructive Surgery to advance surgical education and reconstruction techniques. His clinical mentorship emphasizes multidisciplinary collaboration, particularly in head and neck oncology cases where tumor resection requires immediate reconstruction. Current projects integrate virtual planning with intraoperative navigation to optimize complex defect repair. He operates within the Facial Plastic and Reconstructive Surgery division at the University of Rochester, collaborating with Wilmot Cancer Institute's head and neck oncology team. His practice incorporates virtual surgical planning technology and microvascular reconstruction expertise, with active participation in multidisciplinary tumor boards for complex craniofacial cases.

• Head and Neck Oncology
• Facial Plastic and Reconstructive Surgery
• Skull Base Surgery
• +4 more

Dr. S. Marshal Isaacs is a distinguished Professor of Emergency Medicine at the University of Texas Southwestern Medical School and a senior faculty member at Parkland Hospital's Emergency-Trauma Center. As Medical Director of the Dallas Fire-Rescue Department (DFR), he oversees one of the nation's busiest EMS systems (500 daily incidents, 400+ paramedics). His career includes 12 years as Medical Director for the San Francisco Fire Department, renowned for advancing prehospital care, AED programs, and clinical trials. He collaborates closely with EMS leaders like Drs. Ray Fowler and Kathy Rinnert to enhance Dallas' BioTel System, a 15-municipality EMS federation. Dr. Isaacs' academic roles include NIH-funded research through the ROC consortium and teaching EM residents. His clinical expertise spans otology/neurotology, surgical innovation (e.g., endoscopic ear surgery), and radiation oncology for skull base tumors. He co-authored key NAEMSP texts and pioneered bacteriophage therapy for mastoiditis. Awards include the prestigious Michael K. Copass Award for EMS excellence. Education: Union College, SUNY Stony Brook Medical School (1988), residency at Allegheny General Hospital (Pittsburgh), and a Stanford University EMS fellowship. He served as SFGH's Chief Flight Physician and UCSF faculty before joining UTSW. Current initiatives include the Dallas EMS Vision Process and interdisciplinary NIH projects.

• Emergency Medicine
• Prehospital Care
• Clinical Trials
• +5 more

Allison P Squires is a Professor at the Rory Meyers College of Nursing at New York University (NYU), where she also serves as the Director of the Global Consortium of Nursing and Midwifery Studies (GCNMS), an 82-country research network. She holds affiliated appointments at the Grossman School of Medicine’s Department of General Internal Medicine, the Center for Latin American Studies, and the Center for Drug Use and HIV Research. She is actively accepting PhD students and postdoctoral fellows. PhD in Nursing – Yale University MSN – Duquesne University BSN – University of Pennsylvania Post-Doctoral Fellowship – University of Pennsylvania Her research focuses on global health , immigrant and refugee health , and health services and workforce research , with particular attention to language access, health equity, and pandemic response. She is an expert in implementation science and contextual factors in healthcare delivery. Her recent work examines mental health among nurses during the pandemic, disparities in school-based mental health services, and continuity of care in home health settings. Her publications span global nursing policy , workforce planning , linguistic equity , and cross-cultural research translation . She has served as associate editor of the International Journal of Nursing Studies since 2012 and contributed to major policy initiatives, including the National Academy of Medicine’s 'Future of Nursing 2020–2030' report. Selected honors include: Distinguished Nurse Scholar in Residence, National Academy of Medicine (2019–2020) Fellow, American Academy of Nursing (2015) Outstanding Mentor Award, Academy Health (2023) Chair, Nursing Section, New York Academy of Medicine (2018–2022) Squires has advised numerous research projects and policy analyses, particularly with the World Bank and Migration Policy Institute. She has led initiatives on nursing workforce forecasting, mentoring in Sub-Saharan Africa, and language access in school and home health settings. She is a strong advocate for equitable healthcare and interdisciplinary collaboration. She leads the GCNMS, a major international research consortium, and has developed training programs in gerontology for nurse practitioners. Her work bridges clinical practice, policy, and academic research, with a strong commitment to improving care for vulnerable populations globally.

• Global Health
• Immigrant and Refugee Health
• Health Services Research
• +7 more

Dr. Jason Chan is an Associate Professor in the Department of Radiation Oncology at the University of California, San Francisco (UCSF) School of Medicine. His clinical practice focuses on the treatment of head and neck, skull base, cutaneous, and thoracic malignancies, offering advanced techniques including Cyberknife radiosurgery and high-dose-rate brachytherapy for both initial and repeat radiotherapy. Dr. Chan received his medical degree from Brown University and completed his Internal Medicine internship at Kaiser Permanente San Francisco followed by a residency in Radiation Oncology at UCSF. His academic journey has positioned him as a prominent researcher in head and neck oncology, with particular expertise in HPV-associated oropharyngeal cancer, nasopharyngeal cancer, lung cancer, thyroid cancer, and cutaneous malignancies. His research spans multiple domains including radiation therapy optimization, AI applications in radiation oncology, cancer outcomes research, and translational studies. Dr. Chan's work frequently addresses critical questions in treatment de-escalation for HPV-positive cancers, reirradiation techniques, and health disparities in cancer outcomes. Recent publications demonstrate his leadership in investigating swallowing function outcomes, dosimetric analysis of brachytherapy, and the impact of socioeconomic factors on nasopharyngeal carcinoma outcomes. Dr. Chan actively participates in numerous clinical trials and translational studies, particularly in head and neck and lung cancers. His collaborative approach is evident in his extensive co-authorship network with colleagues at UCSF and other institutions. His work bridges clinical practice with technological innovation, especially in the application of artificial intelligence to radiation therapy planning and delivery. Dr. Chan's research portfolio reflects a commitment to improving both the precision and accessibility of cancer care while addressing significant clinical challenges in radiation oncology.

• Head and Neck Cancer
• Radiation Oncology
• HPV-associated Oropharyngeal Cancer
• +7 more

Fang-Ling Lu is an Associate Professor and Chair of the Department of Communication Sciences and Disorders at UT Health San Antonio. With nearly 30 years of experience, she leads the Speech-Language Pathology Graduate Program and CSD Certificate Program, focusing on clinical expertise and research in motor speech disorders, dysphagia, voice disorders, and tracheostomy care for adult patients with neurological diseases, structural abnormalities, and head and neck cancer. Her research interests center on speech-language pathology, particularly in the context of cochlear implantation and its impact on speech production, voice parameters, and auditory feedback. This aligns with broader studies in phonetics, speech perception, and rehabilitation for hearing-impaired individuals. Dr. Lu can be contacted via email at luf@uthscsa.edu .

• Motor Speech Disorders
• Dysphagia
• Voice Disorders
• +4 more

Stephanie Knollhoff serves as an Assistant Professor in the Department of Speech, Language and Hearing Sciences at the University of Missouri's College of Health Sciences, where she directs the Swallowing and Communication Physiology Exploration (SCoPE) Lab. She teaches graduate courses including Medical Speech-Language Pathology (SLHS 8350), Voice Science and Voice Disorders (SLHS 8225), and Dysphagia (SLHS 8230), while mentoring Honors College students in research. Her academic credentials include a PhD in Speech-Language Pathology from the University of Kansas, a Master of Arts in Speech-Language Pathology from the University of Kansas, and a Bachelor of Science in Communication Sciences and Disorders from Saint Louis University. Dr. Knollhoff's research centers on cancer-related swallowing and communication deficits, with emphasis on head and neck cancer rehabilitation, pediatric dysphagia, and neuroimaging of swallowing physiology using fNIRS. She actively works to improve clinical practice standards and expand access to dysphagia services through education initiatives for current and future professionals. Her work integrates physiological analysis with practical clinical applications to address rehabilitation challenges in oncology settings. Analysis of her 15 most recent publications (2013-2025) reveals a strong trajectory toward pediatric dysphagia education and caregiver experiences in cancer contexts, alongside innovative rehabilitation protocols for head and neck cancer patients. Recent work increasingly focuses on motor imagery therapy for dysphagia and cortical activation mapping during swallowing, while maintaining foundational research in alaryngeal communication and neurodegenerative disease impacts on speech. Dr. Knollhoff actively mentors undergraduate researchers like Rucha Kelkar, whose work examined cancer treatment effects on swallowing physiology. She collaborates on clinical projects improving swallowing rehabilitation participation during radiation therapy and develops protocols to enhance dysphagia service accessibility, particularly for underserved populations. She directs the SCoPE Lab, which investigates swallowing and communication physiology through advanced techniques including fNIRS imaging, articulation pressure measurement, and longitudinal tracking of speech motor changes in cancer and neurodegenerative conditions.

• Swallowing Disorders (Dysphagia)
• Head and Neck Cancer Rehabilitation
• Communication Disorders in Cancer Patients
• +3 more

Eric Hao Ming Yang is a Clinical Professor at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). His clinical and research focus centers on Cardio-Oncology, with expertise in valvular disease, cardiac imaging, and cancer therapy-related cardiovascular toxicity. He is actively engaged in medical education and health disparities research. Education/Training: M.D., University of Illinois at Chicago College of Medicine (2005) Internal Medicine Residency, Harbor-UCLA Medical Center (2008) Cardiovascular Diseases Fellowship, Harbor-UCLA Medical Center (2011) Research Focus: Dr. Yang investigates cardiovascular complications in cancer patients, including chemotherapy-induced cardiotoxicity, immune checkpoint inhibitor myocarditis, and vascular disease. He emphasizes imaging applications (CT, echocardiography) and disparities in cardio-oncology outcomes. His work merges clinical care with translational research to optimize survivorship. Publication Trends: Recent articles (2022-2025) highlight Cardio-Oncology guideline development, imaging innovations, and socioepidemiologic disparities. Dominant themes include SGLT2 inhibitor cardioprotection, immune-related toxicities, and procedural outcomes in high-risk populations like cancer survivors undergoing valve interventions.

• Cardio-Oncology
• Medical Education
• Valvular Disease
• +2 more

Sara J. Knight is a Researcher in the Department of Internal Medicine at the University of Utah School of Medicine, with a focus on genomic medicine, cancer survivorship, and patient-centered decision-making. Her work bridges clinical research with public health, emphasizing health equity, shared decision-making, and quality-of-life outcomes. PhD in Clinical Psychology from Southern Illinois University Carbondale MA in Clinical Psychology from Southern Illinois University Carbondale BA in Psychology from University of Maryland Her research spans genomics and personalized medicine , particularly in underserved populations, and health experiences of veterans with chronic illnesses. She investigates patient preferences , medical decision-making in oncology, and implementation science for genomic sequencing in clinical settings. Recent publications highlight her work on long-term impacts of pandemics , utility of genomic testing , and health disparities in surgical outcomes . She contributes extensively to the CSER Consortium and SouthSeq initiatives, focusing on diverse patient populations. Her methodological expertise includes qualitative analysis , instrument development for measuring genomic utility, and cohort studies assessing interventions like Enhanced Recovery After Surgery (ERAS) pathways.

• Cancer
• Prostate Cancer
• Palliative Medicine
• +7 more

Rodney J. Taylor is a Professor and Chair of the Department of Otorhinolaryngology-Head & Neck Surgery at the University of Maryland School of Medicine. With clinical expertise in head and neck cancer management, skull base surgery, and endocrine surgery, he has led national-recognized research initiatives since joining the faculty in 2001. As Chief of Otolaryngology at the Baltimore Veteran’s Administration Medical Center, he combines clinical excellence with scientific innovation. Education : MD from Harvard Medical School (1995), MPH from University of Michigan School of Public Health (1999) Training : Residency in Otolaryngology-Head & Neck Surgery at University of Michigan (1995-2001) Dr. Taylor's research focuses on improving head and neck cancer survival through immune-cytotoxicity studies, SCCHN cell line analysis, xenograft models, and clinical trials. His collaborations with Dr. Zalzman's lab explore cancer stem cell immortality mechanisms and regenerative medicine advancements. Current research also investigates NK cell FcγRIIIa polymorphisms for personalized antibody therapy. Scientific achievements include developing the Neck Dissection Impairment Index and recognition as a top otolaryngologist. His lab secures funding from NIH, DOD, and philanthropic sources like the Orokawa Foundation and Weitzman family. Research trends emphasize translational oncology, immunotherapy, and stem cell applications in head and neck diseases. Scientific Awards : Ranked among 'America’s Top Otolaryngologists'

• Head and Neck Surgical Oncology
• Rhinology and Sinus Disease
• Endocrine Surgery
• +7 more

Ignatius Nip is an Associate Professor and Director at the School of Speech Language and Hearing Sciences at San Diego State University. His research focuses on speech motor control and development in individuals with neurogenic speech disorders such as dysarthria in cerebral palsy, Parkinson's disease, and head and neck cancer survivors. PhD in Communication Disorders (University of Nebraska-Lincoln, 2007) MSLP in Speech-Language Pathology (University of Alberta, 2001) BA in Speech Science (University of British Columbia, 1999) Research spans speech physiology , kinematic analysis , and neurogenic motor control . Recent studies examine pronoun comprehension in developmental disorders, deep-brain stimulation effects on speech, and articulatory patterns in cerebral palsy. Certifications include ASHA Certificate of Clinical Competence (2007-2021) and California Speech-Language Pathology License (2011-2021) . Publications appear in journals like Child Development and Journal of Speech Language and Hearing Research .

• Speech Motor Control
• Neurogenic Speech Disorders
• Dysarthria
• +5 more

Jennifer De Los Santos, MD is a Professor of Radiation Oncology at Washington University School of Medicine in St. Louis. She serves in the Department of Radiation Oncology and is part of the Siteman Cancer Center. Dr. De Los Santos is a nationally recognized expert in breast cancer although her current clinical and research focus centers on cancers of the head and neck. She has held leadership positions including Chairman of Radiation Oncology and Cancer Center Director at Grandview Cancer Center in Birmingham, Alabama, and has led national studies in breast cancer through the TBCRC and NRG oncology groups. Dr. De Los Santos' educational background includes a BS in Psychology from Emory University (1991), an MD from the University of Florida (1995), and completed her residency in Radiation Oncology at MD Anderson Cancer Center (2001). Her research interests span breast cancer treatment, radiation therapy techniques, and head and neck cancers, with particular focus on developing paradigm-shifting treatment approaches and translational work to define populations who may successfully proceed with these approaches. Her publication record demonstrates consistent productivity with 68 research outputs and 2973 citations. Recent work shows a strong focus on breast cancer staging systems, pathological response prediction, and innovative treatment approaches including novel combinations of targeted therapies with radiation. Her research often involves large national clinical trials through NRG Oncology and other cooperative groups. Dr. De Los Santos has served in leadership roles at the Translational Breast Cancer Research Consortium (TBCRC), the University of Alabama at Birmingham, and has been involved in numerous national clinical trials that have shaped breast cancer treatment guidelines. Her work bridges clinical practice and research, with emphasis on improving outcomes for cancer patients through innovative treatment approaches and better understanding of treatment response predictors.

• Breast Cancer
• Radiation Therapy
• Head and Neck Cancers
• +5 more

Stephen E. Sallan, MD , is a Professor of Pediatrics at Harvard Medical School and a Physician at Dana-Farber Cancer Institute and Children's Hospital . His career spans over five decades in pediatric hematology/oncology , with a focus on acute lymphoblastic leukemia (ALL) and pediatric brain tumors . Education : MD, Wayne State University School of Medicine (1967) Residencies : Boston Floating Hospital (1968), Children's Hospital of Philadelphia (1969), Hospital for Sick Children, London (1970) Fellowship : Pediatric Oncology, Children's Hospital/DFCI (1972) Leadership Roles : Chief of Staff (1995), Chairman of Medical Staff Executive Committee (1995), Chief of Staff Emeritus (2012) Dr. Sallan's research integrates genetic heterogeneity , disease recurrence , and drug resistance in ALL, with efforts to develop targeted therapies like tumor vaccines and antiangiogenesis agents. His work addresses long-term treatment toxicities (cardiac, skeletal, neurocognitive), particularly in survivors of childhood cancers. His 15 most recent publications (2024–2018) demonstrate ongoing engagement with pharmacogenomics, thrombosis risk models, dietary interventions, and molecular markers in brain tumors. Key subfields include TRK-C in medulloblastoma , asparaginase complications , and DFCI ALL Consortium Protocols . Scientific Awards : Distinguished Alumni Award, Wayne State University School of Medicine (1997) James Carreras Prize for International Pediatrician of the Year (1987) As a leader in pediatric leukemia research , Dr. Sallan has shaped treatment protocols that minimize late effects while improving survival. He collaborates with multidisciplinary teams in neuro-oncology and pharmacogenomics, maintaining active roles in clinical trials and laboratory investigations.

• Acute Lymphoblastic Leukemia
• Pediatric Brain Tumors
• Genetic Heterogeneity
• +5 more